These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 6801076

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative study of human fetal, normal adult, and somatotropic adenoma pituitary function in tissue culture.
    Marcovitz S, Goodyer CG, Guyda H, Gardiner RJ, Hardy J.
    J Clin Endocrinol Metab; 1982 Jan; 54(1):6-16. PubMed ID: 6119321
    [No Abstract] [Full Text] [Related]

  • 4. Interactions of steroids with prolactin secretion in vitro.
    Lamberts SW.
    Horm Res; 1985 Jan; 22(3):172-8. PubMed ID: 4054837
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine.
    Israel JM, Jaquet P, Vincent JD.
    Endocrinology; 1985 Oct; 117(4):1448-55. PubMed ID: 4029087
    [Abstract] [Full Text] [Related]

  • 8. In vitro studies on prolactin release and adenylate cyclase activity in human prolactin-secreting pituitary adenomas. Different sensitivity of macro- and microadenomas to dopamine and vasoactive intestinal polypeptide.
    Spada A, Nicosia S, Cortelazzi L, Pezzo G, Bassetti M, Sartorio A, Giannattasio G.
    J Clin Endocrinol Metab; 1983 Jan; 56(1):1-10. PubMed ID: 6292253
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of dopamine and alpha-adrenergic receptors in human prolactin-secreting adenomas with [3H]-dihydroergocryptine.
    Ramsdell JS, Bethea CL, Jaffe RB, Wilson CB, Weiner RI.
    Neuroendocrinology; 1985 Jun; 40(6):518-25. PubMed ID: 2861582
    [Abstract] [Full Text] [Related]

  • 10. Direct action of opiates on bromocriptine-inhibited prolactin release by human prolactinoma cells in primary culture.
    Castanas E, Jaquet P, Gunz G, Cantau P, Giraud P.
    J Clin Endocrinol Metab; 1985 Nov; 61(5):963-8. PubMed ID: 2995431
    [Abstract] [Full Text] [Related]

  • 11. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
    Jaquet P, Hassoun J, Delori P, Gunz G, Grisoli F, Weintraub BD.
    J Clin Endocrinol Metab; 1984 Nov; 59(5):817-24. PubMed ID: 6480809
    [Abstract] [Full Text] [Related]

  • 12. Tamoxifen enhances the sensitivity of dispersed prolactin-secreting pituitary tumor cells to dopamine and bromocriptine.
    de Quijada M, Timmermans HA, Lamberts SW, MacLeod RM.
    Endocrinology; 1980 Mar; 106(3):702-6. PubMed ID: 6766385
    [No Abstract] [Full Text] [Related]

  • 13. Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
    Woolf PD.
    Am J Physiol; 1981 Jun; 240(6):E700-4. PubMed ID: 7246736
    [Abstract] [Full Text] [Related]

  • 14. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH, Figueroa CD, Smith CM, Bhoola KD.
    Agents Actions Suppl; 1992 Jun; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [Abstract] [Full Text] [Related]

  • 15. [Pregnancy in a subject with prolactin-secreting pituitary adenoma during therapy with bromocriptine].
    Passannanti G, Cardone A, Marafioti F, Alvino N.
    Riv Ital Ginecol; 1980 Jun; 59 Suppl():87-91. PubMed ID: 7347889
    [No Abstract] [Full Text] [Related]

  • 16. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

  • 17. Hormone secretion by dispersed cell cultures of human pituitary adenomas: effects of theophylline, thyrotropin-releasing hormone, somatostatin, and 2-bromo-alpha-ergocryptine.
    Adams EF, Brajkovich IE, Mashiter K.
    J Clin Endocrinol Metab; 1979 Jul; 49(1):120-6. PubMed ID: 109461
    [No Abstract] [Full Text] [Related]

  • 18. Decreased responsiveness of GH3 cells to the dopaminergic inhibition of prolactin.
    Faure N, Cronin MJ, Martial JA, Weiner RI.
    Endocrinology; 1980 Oct; 107(4):1022-6. PubMed ID: 6157521
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Establishment and characterization of a new human cultured cell line from a prolactin-secreting pituitary adenoma.
    Kikuchi Y, Seki K, Momose E, Kizawa I, Oomori K, Shima K, Mukai K, Kato K.
    Cancer Res; 1985 Nov; 45(11 Pt 2):5722-7. PubMed ID: 4053045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.